A small Chinese study has reported that 15 of 28 young type 1 patients, aged 14 to 30 years, who underwent an experimental adult stem
Diamyd is forging ahead with a Phase III human trial of DiaPrevent, a potentially new treatment that can stop or slow the destruction of insulin-producing
A new service has been launched on the Diabetes UK website to help people with diabetes get involved in research. By participating in a clinical
Because of evidence that beta-cell failure occurs earlier and more severely in patients with type 2 diabetes, a new consensus statement suggests that greater emphasis
New research suggests that feeding a baby that may be predisposed to Type 1 diabetes with a certain type of baby formula when weaning off
Dallas-based Access Pharmaceuticals said that it will begin testing a new oral insulin drug in humans, according to a recent article from The Dallas Morning
Researchers say that when they artificially induced Type 1 diabetes in mice in a recent study, alpha cells converted into insulin-producing beta cells, according to
In recent years a new categorization known as Type 1.5 Diabetes, or Latent Autoimmune Diabetes in Adults (LADA), has gained increasing acceptance. The terms are
In September 2010 Diabetes UK and the Chief Scientist Office (CSO) of the Scottish Government announced that joint funding of over £675,000 to establish a
Urban air pollution — especially the particles and gases spewed by heavy traffic — can increase a senior citizen’s risk of developing type-2 diabetes, according
